Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Vaccine trial for equine grass sickness
Study in preparation for a nationwide vaccine trial

It has been announced that the Animal Health Trust (AHT) and the Royal (Dick) School of Veterinary Studies of the University of Edinburgh, will be conducting a small pilot vaccine trial to protect against equine grass sickness.

Following approval by the Veterinary Medicines Directorate, the pilot study is set to take place in eastern Scotland, since equine grass sickness was first reported in the region more than a century ago.

The pilot study is in preparation for a full nationwide vaccine trial involving at least 1000 horses and ponies. This will likely commence in 2014, but is subject to securing sufficient funding.

The Equine Grass Sickness Fund is leading a campaign in order to raise money for the full vaccine trial.

The AHT has great hopes that these vaccine trials will mark an enormous breakthrough in the prevention of the disease. Although there is still a lot of work to do before launching the full nationwide vaccine trial, this initial pilot study will help to ensure that the trial design will be practical to perform on a larger scale.

Kate Thomson, spokesperson for the Equine Grass Sickness Fund, said: "We are over the moon that the pilot vaccine trial has begun, but fundraising now starts in earnest to ensure that the full trial can go ahead.

"Grass sickness brings about a devastating annual toll, and we are appealing to every horse owner in the UK to help bring an end to this disease by donating to this cause."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'